PharmSource - Cell Therapy Market Opportunity for CMOs - 2018 Edition
June 2018
70
About the Report
About the Report
PharmSource-Cell Therapy Market Opportunity for CMOs-2018 Edition
Summary
This PharmSource Trend Report will explore whether the bio/pharma industry is adequately prepared for future cell therapy developments and whether pharma companies and contract manufacturing organizations (CDMOs) are making appropriate investments in the capacity and technology to support the coming opportunity.
This 35-page report gives important, expert insight you won't find in any other source. 16 tables and figures throughout the report illustrate major points and trends.
Scope
This report seeks to achieve the following objectives-
- To describe and evaluate the cell therapy market opportunity;
- To describe and address the adequacy of the network of CDMOs that manufacture for the cell therapy market, both clinical and commercial;
- To assess the outlook for buyers and sellers of contract manufacturing services for cell therapies, including the supply/demand balance.
Reasons to buy
This report is required reading for-
- CMO executives who must have deep understanding of the Cell Therapy marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Pharmaceutical and Biotech companies involved in the development of Cell Therapies or Cell Therapy technologies.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Products
Products
AAV, Electroporation, Lentivector, Retrovirus, Cryovials, Prefilled syringe, Vials, Closed-system bag Filling, Cryobags, Analytical methods development, Biosafety testing, Cell banking, Cell line development, Fill and finish, Formulation development, Microbiology, Process development, Stability testing, Allogeneic Cell Source, Autologous Cell Source, Dendritic cells, Embryonic stem cells, Mesenchymal Stromal cells, NK cells, T cells, Provenge, Yescarta, Kymriah, Maci, Gintuit, Carticel, chimeric antigen receptors T cell (CAR-T)
Companies
Cellectis
China PLA General Hospital
GSK
3P Biopharmaceuticals
Abzena
Anemocyte SRL
apceth Biopharma GmbH
Areta International
Army Military Medical University (formerly Third Military Medical University)
Astellas
Atvio Biotech Ltd
Austrianova Singapore Pte. Ltd.
Autolus
Bio Elpida
Bioinova sro
Brammer Bio
CCRM
Celgene
Cell and Gene Therapy Catapult
CellforCure
Cellin Technologies LLC
Cellular Therapeutics Ltd.
Celularity
City of Hope
Cognate Bioservices
Cook General BioTechnology, LLC
Dendreon Pharmaceuticals LLC
Esperite
Fraunhofer Group
GE Healthcare
Gencure
Gilead Sciences Inc.
Histocell SL
Hitachi Chemical Co Ltd
Hitachi Chemical Co., Ltd.
Holostem Terapie Avanzate
Incell Corporation LLC
International Stem Cell Corporation
Japan Tissue Engineering
Johnson & Johnson
KBI Biopharma
Kite
Kite Pharma Inc.
Lonza Group
Lonza Netherlands
MaSThercell
Medinet
MolMed SpA
New York Blood Center, Inc
Newcastle University
NHS Blood and Transplant
Nikon Corporation
Novartis International AG
Novartis Pharmaceuticals Corp.
Organogenesis Inc.
Oxford Biomedica
Pfizer
Provia Laboratories LLC
Roslin Cell Therapies
Sanpower Group Co Ltd
Sanquin Blood Supply Foundation
Shenzhen Geno-Immune Medical Institute
Stem Cell and Cancer Institute (SCI)
Takara Bio
University College London
University of Edinburgh
University of Miami Health System
University of Minnesota
University of Pittsburgh
University of Utah Health
Vericel Corp.
WuXi AppTec
Yposkesi
Table of Contents
Table of Contents
Table of Contents
1. Executive Summary 4
2. Introduction 5
3. Commercial Cell Therapy Experience 7
4. Cell Therapy Pipeline 10
5. Next-Generation Technologies 13
6. Approvals Outlook 15
7. Cell Therapy Supply Chain 16
8. Demand Models 23
9. What It Means 25
10. Notes on Methodology 28
11. Appendix 32
List of Figure
List of Figures
Figure 1: Kymriah Global Sales Forecast 2018-2024 (USDB) 8
Figure 2: Yescarta Global Sales Forecast 2018-2024 (USDB) 9
Figure 3: Pipeline Cell Therapy Candidates 10
Figure 4: Phase I Trial Starts by Sponsor Type 11
Figure 5: Phase II Planned Trial Starts by Sponsor Type 12
Figure 6: Phase III Planned Trial Starts by Sponsor Type 12
List of Table
List of Tables
Table 1 : FDA-Approved, Marketed Cell Therapies 7
Table 2: Cell Therapy Approvals 15
Table 3: Cell Therapy CDMOs' Biological Services 17
Table 5: Cell Therapy CDMOs' Packaging Capabilities 19
Table 6: Cell Therapy CDMO Sites and Associated Cell Source and Types 21
Table 7: Method of Transfection Used at Cell Therapy CDMO Sites 23
Table 8: Model for Cell Therapy Clinical Requirements 24
Table 9: Model for Cell Therapy Commercial Requirements 25
Table 10: Model for Yearly Cell Therapy Commercial Requirements 31
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.